Correlation Between Enliven Therapeutics and Replimune
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Replimune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Replimune into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Replimune Group, you can compare the effects of market volatilities on Enliven Therapeutics and Replimune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Replimune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Replimune.
Diversification Opportunities for Enliven Therapeutics and Replimune
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Enliven and Replimune is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Replimune Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Replimune Group and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Replimune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Replimune Group has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Replimune go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Replimune
Given the investment horizon of 90 days Enliven Therapeutics is expected to under-perform the Replimune. But the stock apears to be less risky and, when comparing its historical volatility, Enliven Therapeutics is 1.31 times less risky than Replimune. The stock trades about -0.09 of its potential returns per unit of risk. The Replimune Group is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 1,256 in Replimune Group on November 3, 2024 and sell it today you would earn a total of 142.00 from holding Replimune Group or generate 11.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Replimune Group
Performance |
| Timeline |
| Enliven Therapeutics |
| Replimune Group |
Enliven Therapeutics and Replimune Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Replimune
The main advantage of trading using opposite Enliven Therapeutics and Replimune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Replimune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Replimune will offset losses from the drop in Replimune's long position.| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
| Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets |